| Powerback Rehabilitation | |
|
6901 Carslaw Ct, Prospect, KY 40059-8358 | |
| (502) 480-1794 | |
| Not Available |
| Full Name | Powerback Rehabilitation |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 6901 Carslaw Ct, Prospect, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063014405 | NPI | - | NPPES |
| Provider Name | James Li |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1598036022 PECOS PAC ID: 0244283497 Enrollment ID: I20050228000598 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Amy Klein Wheatley |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1114261971 PECOS PAC ID: 2365467115 Enrollment ID: I20051011000228 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Joy R Suwinski |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1922233972 PECOS PAC ID: 7719039916 Enrollment ID: I20090720000260 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Carolyn Lawson |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1528629979 PECOS PAC ID: 4385971639 Enrollment ID: I20190808002065 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Melanie P Morgan |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1326311473 PECOS PAC ID: 4486061207 Enrollment ID: I20210323001978 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Patrick T Holt |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1558605964 PECOS PAC ID: 7719394485 Enrollment ID: I20210324001747 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Andrea Mccarthy Ritter |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1447400684 PECOS PAC ID: 3375945447 Enrollment ID: I20210712003190 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Erin S Barnes |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1508198151 PECOS PAC ID: 5395147482 Enrollment ID: I20210712004064 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Andrea Wrenn |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1881093565 PECOS PAC ID: 3678971249 Enrollment ID: I20211012002772 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Lori B Dietz |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1376739573 PECOS PAC ID: 9335532514 Enrollment ID: I20220210002659 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Brooke K Humble |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1336483734 PECOS PAC ID: 6507253564 Enrollment ID: I20220422000399 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Joshua S Chappell |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1649651449 PECOS PAC ID: 5193112928 Enrollment ID: I20220426002949 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Laynee Morgan Osborne |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1275932360 PECOS PAC ID: 2860872165 Enrollment ID: I20220705001033 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Christine Gayle Medina |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1164000139 PECOS PAC ID: 0143604884 Enrollment ID: I20220830003102 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Cassandra White |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1174864698 PECOS PAC ID: 5799153557 Enrollment ID: I20221129000960 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Amanda Hamilton |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1467164533 PECOS PAC ID: 2466824305 Enrollment ID: I20230202001356 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Emilee M Longshore |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1457833220 PECOS PAC ID: 9436521051 Enrollment ID: I20230208001649 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Susan Buscher |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1700595048 PECOS PAC ID: 6204200959 Enrollment ID: I20230320000968 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Tyler Scott Lindsey |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1730700964 PECOS PAC ID: 1951766138 Enrollment ID: I20230421000860 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Adam Molony |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1134537087 PECOS PAC ID: 5294190906 Enrollment ID: I20230503000388 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Ashley Lynn Davis |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1225724529 PECOS PAC ID: 1355707670 Enrollment ID: I20230511001867 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Amy Marie Cline |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1114628799 PECOS PAC ID: 8123484110 Enrollment ID: I20230517001982 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Sean Michael Sullivan |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1053004580 PECOS PAC ID: 3779943279 Enrollment ID: I20230715000467 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Kevin Richard Schoenfeld |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1528771516 PECOS PAC ID: 1355703414 Enrollment ID: I20230822001109 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Morgan Messina |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1215674205 PECOS PAC ID: 3577926054 Enrollment ID: I20230831000249 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Jayna Nichole Willis |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1447765136 PECOS PAC ID: 6204283641 Enrollment ID: I20231107002685 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Provider Name | Jeff Thomas Reinstatler |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1275316143 PECOS PAC ID: 1456701176 Enrollment ID: I20231221000859 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Powerback Rehabilitation 101 E State St, Kennett Square, PA 19348-3109 Ph: (800) 728-8808 | Powerback Rehabilitation 6901 Carslaw Ct, Prospect, KY 40059-8358 Ph: (502) 480-1794 |
News Archive
"The U.S. government on Thursday released a new policy that will require federal agencies to systematically review the potential risks associated with federally funded studies involving 15 'high consequence' pathogens and toxins, including the H5N1 avian influenza virus," Science Insider reports.
The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.
Branch points in the arteries are a common area of atherosclerotic disease, resulting in the occlusion of both branches. These branch points can generally be defined as a main branch and a side branch, and, in treating the disease, the question of what is the optimal course of action, opening the main branch, the side branch, or both, remains uncertain.
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
› Verified 3 days ago
Lindsey Nicole Ketcham, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 6005 Timber Ridge Dr, Prospect, KY 40059 Phone: 502-292-0800 Fax: 502-292-0400 | |
Julie Mangeot, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5405 Killinur Dr, Prospect, KY 40059 Phone: 502-526-3828 | |
Dalton Matthew O'brien, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 6005 Timber Ridge Dr, Prospect, KY 40059 Phone: 502-292-0800 Fax: 502-292-0400 | |
Mrs. Laura Elaine Stone, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9409 Chanteclair Dr, Prospect, KY 40059 Phone: 502-262-2009 Fax: 502-326-8992 | |
Mrs. Karen Anne Causey, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 12902 Willowcreek Rd, Prospect, KY 40059 Phone: 502-228-7993 Fax: 502-228-7993 | |
Kathryn Schneider Roy, PT,DPT, ATC Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5919 Timber Ridge Dr, Suite 101, Prospect, KY 40059 Phone: 502-292-0800 Fax: 502-292-0400 |